Enrique Lerma Selected Research

Carcinoma (Carcinomatosis)

11/2011	Low-density lipoprotein receptor-related protein 1 is associated with proliferation and invasiveness in Her-2/neu and triple-negative breast carcinomas.
12/2009	Triple negative breast carcinomas: similarities and differences with basal like carcinomas.
11/2007	Immunohistochemical heterogeneity of breast carcinomas negative for estrogen receptors, progesterone receptors and Her2/neu (basal-like breast carcinomas).
3/2005	Phenotypic characterization of BRCA1 and BRCA2 tumors based in a tissue microarray study with 37 immunohistochemical markers.
11/2002	Alterations of the p16/Rb/cyclin-D1 pathway in vulvar carcinoma, vulvar intraepithelial neoplasia, and lichen sclerosus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Enrique Lerma Research Topics

Disease

33	Neoplasms (Cancer) 01/2022 - 11/2002
23	Breast Neoplasms (Breast Cancer) 01/2021 - 03/2005
5	Carcinoma (Carcinomatosis) 11/2011 - 11/2002
4	Thyroid Neoplasms (Thyroid Cancer) 01/2021 - 12/2005
3	Necrosis 03/2014 - 11/2007
3	Uterine Cervical Neoplasms (Cancer of the Cervix) 03/2012 - 01/2008
2	Inflammation (Inflammations) 11/2020 - 01/2013
2	Neoplasm Metastasis (Metastasis) 01/2020 - 09/2009
2	Adenocarcinoma 11/2016 - 03/2012
1	Hypertension (High Blood Pressure) 01/2022
1	Hyperplasia 01/2022
1	Lymphatic Metastasis 01/2021
1	Ovarian Neoplasms (Ovarian Cancer) 01/2021
1	Atherosclerosis 11/2020
1	Ventricular Remodeling 10/2020
1	Myocardial Infarction 10/2020
1	Head and Neck Neoplasms (Head and Neck Cancer) 01/2020
1	Fanconi Anemia (Fanconi's Anemia) 01/2020
1	Chromosome Fragility 01/2020
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020
1	Squamous Cell Carcinoma of Head and Neck 01/2020
1	Obesity 02/2019
1	Papillary Thyroid Cancer 01/2019
1	Anaplastic Thyroid Carcinoma 01/2019
1	Endometrial Neoplasms (Endometrial Cancer) 01/2019
1	Diabetic Neuropathies (Diabetic Neuropathy) 01/2018
1	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 01/2018
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2018
1	Fibrosis (Cirrhosis) 01/2018
1	Hyperalgesia 01/2018
1	Neuralgia (Stump Neuralgia) 01/2018
1	Tachycardia (Tachyarrhythmias) 01/2018
1	Dyslipidemias (Dyslipidemia) 01/2018
1	Chronic Pain 01/2018
1	Carcinogenesis 06/2015
1	Wilms Tumor (Wilm's Tumor) 08/2014
1	Hemorrhage 08/2014

Drug/Important Bio-Agent (IBA)

9	Messenger RNA (mRNA)IBA 01/2017 - 09/2009
8	Phenobarbital (Luminal)FDA Link 01/2018 - 12/2009
7	Proteins (Proteins, Gene)FDA Link 06/2015 - 10/2005
6	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2013
5	Lipoproteins (Lipoprotein)IBA 01/2021 - 01/2013
5	CholesterolIBA 01/2021 - 11/2011
5	Hormones (Hormone)IBA 01/2016 - 03/2005
4	Estrogen ReceptorsIBA 01/2018 - 11/2007
4	DNA (Deoxyribonucleic Acid)IBA 02/2011 - 01/2008
3	HDL LipoproteinsIBA 01/2021 - 01/2018
3	LDL Receptors (LDL Receptor)IBA 01/2021 - 11/2011
3	LDL CholesterolIBA 01/2021 - 11/2011
3	MicroRNAs (MicroRNA)IBA 01/2021 - 06/2015
3	ApolipoproteinsIBA 11/2020 - 11/2016
3	Biological ProductsIBA 02/2011 - 09/2003
2	27-hydroxycholesterolIBA 01/2021 - 01/2019
2	HDL CholesterolIBA 01/2021 - 11/2016
2	Scavenger Receptors (Scavenger Receptor)IBA 01/2021 - 06/2015
2	AntioxidantsIBA 01/2021 - 02/2019
2	oxidized low density lipoproteinIBA 01/2021 - 11/2016
2	LipidsIBA 10/2020 - 11/2012
2	Apolipoprotein A-I (Apolipoprotein A1)IBA 02/2019 - 11/2016
2	Pharmaceutical PreparationsIBA 01/2018 - 01/2013
2	human ERBB2 proteinIBA 01/2018 - 12/2009
2	Tumor Viral Antigens (Large T Antigen)IBA 11/2016 - 01/2013
2	OsteopontinIBA 06/2015 - 03/2014
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2015 - 01/2007
2	RNA (Ribonucleic Acid)IBA 03/2014 - 11/2012
2	Complementary DNA (cDNA)IBA 03/2014 - 12/2009
2	VaccinesIBA 03/2012 - 11/2010
2	Cadherins (E-Cadherin)IBA 01/2011 - 03/2005
2	Progesterone Receptors (Progesterone Receptor)IBA 08/2008 - 11/2007
2	NF-kappa B (NF-kB)IBA 11/2007 - 01/2007
2	Caspase 3 (Caspase-3)IBA 11/2007 - 03/2005
2	Coloring Agents (Dyes)IBA 05/2007 - 07/2003
2	Cyclin D1IBA 03/2005 - 11/2002
1	MineralocorticoidsIBA 01/2022
1	LDL Lipoproteins (beta Lipoproteins)IBA 01/2021
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2021
1	Apolipoproteins B (ApoB)IBA 11/2020
1	Apolipoproteins E (ApoE)IBA 11/2020
1	Niacinamide (Nicotinamide)FDA LinkGeneric 11/2020
1	AfatinibIBA 01/2020
1	Gefitinib (Iressa)FDA Link 01/2020
1	prolinedithiocarbamate (PDTC)IBA 01/2019
1	tricarbonyldichlororuthenium (II) dimerIBA 01/2018
1	Carbon MonoxideIBA 01/2018
1	CollagenIBA 01/2018
1	Streptozocin (Streptozotocin)FDA Link 01/2018
1	Hyaluronic Acid (Hyaluronan)IBA 01/2017
1	Peptides (Polypeptides)IBA 11/2016
1	Acetyl-CoA C-Acetyltransferase (Acetyl Coenzyme A Acetyltransferase)IBA 06/2015
1	Cholesterol Esters (Cholesteryl Esters)IBA 06/2015
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 06/2015
1	Indicators and Reagents (Reagents)IBA 06/2015
1	AnthracyclinesIBA 10/2014
1	AS 8IBA 08/2014
1	Etoposide (VP 16)FDA LinkGeneric 08/2014
1	IntegrinsIBA 03/2014

Therapy/Procedure

5	Therapeutics 01/2021 - 01/2007
1	Lymph Node Excision (Lymph Node Dissection) 01/2020
1	Neoadjuvant Therapy 10/2014
1	Surgical Instruments (Clip) 08/2014